NKGen Biotech Korea Co., Ltd.(KR:182400)
KR:182400
NKGen Biotech Korea Co., Ltd. ownership
NKGen Biotech Korea Co., Ltd. (182400) Ownership - Who Owns NKGen Biotech Korea Co., Ltd.?
NKGen Biotech Korea Co., Ltd. (182400) Ownership Overview
- 0.52% Mutual Funds
- 0.57% ETFs
- 98.91% Public Companies and Individual Investors
The ownership structure of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is a mix of institutional, retail, and individual investors. Approximately 1.09% of the company’s stock is owned by Institutional Investors, and 98.91% is owned by Public Companies and Individual Investors.
The ownership structure of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is a mix of institutional, retail, and individual investors. Approximately 1.09% of the company’s stock is owned by Institutional Investors, and 98.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 363,221 | Institution | 0.50% | ― |
| Vanguard Star Funds | 177,790 | Institution | 0.25% | ― |
| Vanguard Tax-managed Funds | 107,914 | Institution | 0.15% | ― |
| Vanguard International Equity Index Funds | 73,363 | Institution | 0.10% | ― |
| State Street | 45,916 | Institution | 0.06% | ― |
| State Street Institutional Investment Trust | 18,462 | Institution | 0.03% | ― |
| Spdr | 3,802 | Institution | <0.01% | ― |
| Hsbc | 1,277 | Institution | <0.01% | ― |
| Invesco | 154 | Institution | <0.01% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 177,790 | Institution | 0.25% | ― |
| Vanguard Tax-managed Funds | 107,914 | Institution | 0.15% | ― |
| Vanguard International Equity Index Funds | 73,363 | Institution | 0.10% | ― |
| State Street Institutional Investment Trust | 18,462 | Institution | 0.03% | ― |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total International Stock ETF, VXUS ETF | 177,790 | Institution | 0.25% | 1,278,494 |
| Vanguard FTSE Developed Markets ETF, VEA ETF | 107,914 | Institution | 0.15% | 776,014 |
| Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF | 49,027 | Institution | 0.07% | 347,554 |
| SPDR S&P International Small Cap ETF, GWX ETF | 39,090 | Institution | 0.05% | 14,776 |
| Vanguard FTSE Pacific ETF, VPL ETF | 15,367 | Institution | 0.02% | 110,505 |
| Vanguard Total World Stock ETF, VT ETF | 8,969 | Institution | 0.01% | 64,496 |
| SPDR Portfolio MSCI Global Stock Market ETF, SPGM ETF | 6,826 | Institution | <0.01% | 2,580 |
| SPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD, GB:EMSM ETF | 3,116 | Institution | <0.01% | 5,595 |
| Vanguard ESG International Stock ETF, VSGX ETF | 2,034 | Institution | <0.01% | 5,585 |
| Vanguard exNA Idx Un, TSE:VIU ETF | 1,870 | Institution | <0.01% | 18,175 |
FAQ
What percentage of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.09% of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by institutional investors: 0.52% by mutual funds and 0.57% by ETFs.
What percentage of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.91% of NKGen Biotech Korea Co., Ltd. (KR:182400) stock is held by public companies and individual investors.
Who owns the most shares of NKGen Biotech Korea Co., Ltd. (KR:182400)?
Vanguard owns the most shares of NKGen Biotech Korea Co., Ltd. (KR:182400).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

